Skip to content
8-K

Material Event

Aprea Therapeutics, Inc. APRE

0001104659-26-036821

← back to feed
Filed
Mar 30, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Structured financials aren't available for this filing — it may be an event-driven form (8-K/6-K), pre-date XBRL (~2009), or report only narrative content. Use the SEC.gov links above to read it.